IP Library › Granted Patent US 8,759,501
Granted Patent B2
US 8,759,501 · App. 12/523,631 · Granted Jun 24, 2014

Oligosaccharides comprising an aminooxy group and conjugates thereof

Inventors: Yunxiang Zhu (Wayland, MA); Seng H. Cheng (Natick, MA); Canwen Jiang (Southborough, MA); Luis Z. Avila (Arlington, MA)
Assignee: Genzyme Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,759,501
App. No.
12/523,631
Granted
Jun 24, 2014
Kind
B2
Abstract

The invention provides methods for the synthesis of oligosaccharides comprising an aminooxy group. The invention further provides oligosaccharides comprising an aminooxy group, methods for coupling oligosaccharides comprising an aminooxy group to glycoproteins, and oligosaccharide-protein conjugates. Also provided are methods of treating a lysosomal storage disorder in a mammal by administration of an oligosaccharide-protein conjugate.

Claims (20)

1. An oligosaccharide of Formula IV:

wherein m and p are independently chosen from integers ranging from 1 to 10.

2. The oligosaccharide of claim 1 , wherein m is 3.

3. The oligosaccharide of claim 1 , wherein p is 1.

4. The oligosaccharide of claim 1 , wherein m is 3 and p is 1.

5. A modified lysosomal enzyme prepared by coupling a glycosylated lysosomal enzyme to the oligosaccharide of Formula IV:

wherein m and p are independently chosen from integers ranging from 1 to 10.

6. The modified lysosomal enzyme of claim 5 , wherein the lysosomal enzyme is acid alpha-glucosidase.

7. A modified lysosomal enzyme comprising a glycosylated lysosomal enzyme coupled to the oligosaccharide of Formula IV through an oxime group, wherein the oligosaccharide of Formula IV is:

wherein m and p are independently chosen from integers ranging from 1 to 10.

8. The modified lysosomal enzyme of claim 7 , wherein the lysosomal enzyme is acid alpha-glucosidase.

9. A method of treating a lysosomal storage disease comprising administering the modified lysosomal enzyme of claim 7 to a patient in need thereof.

10. The method of claim 9 , wherein the lysosomal storage disease is Pompe disease.

11. The method of claim 9 , wherein the lysosomal enzyme is acid alpha-glucosidase.

12. The modified lysosomal enzyme of claim 5 , wherein m is 3.

13. The modified lysosomal enzyme of claim 5 , wherein p is 1.

14. The modified lysosomal enzyme of claim 5 , wherein m is 3 and p is 1.

15. The modified lysosomal enzyme of claim 7 , wherein m is 3.

16. The modified lysosomal enzyme of claim 7 , wherein p is 1.

17. The modified lysosomal enzyme of claim 7 , wherein m is 3 and p is 1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2021
From: ZHU, YUNXIANG; CHENG, SENG H.; JIANG, CANWEN; AVILA, LUIS Z.
To: GENZYME CORPORATION
Reel/Frame 055162/0089 →
Continuity (2)
Provisional Application 60885471 · Jan 18, 2007
Related Publication 20100047225A1 · Feb 25, 2010